Abou Najem, S., Khawaja, G., Hodroj, M. H., Babikian, P., & Rizk, S. (2019). Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells.
Chicago Style (17th ed.) CitationAbou Najem, Sonia, Ghada Khawaja, Mohammad Hassan Hodroj, Patil Babikian, and Sandra Rizk. Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells. 2019.
MLA (9th ed.) CitationAbou Najem, Sonia, et al. Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells. 2019.
Warning: These citations may not always be 100% accurate.